Dr. Reddy's Laboratories Ltd. (RDY)

36.25
0.82 2.21
NYSE : Health Technology
Prev Close 37.07
Open 36.72
Day Low/High 36.25 / 36.91
52 Wk Low/High 29.00 / 42.82
Volume 137.12K
Avg Volume 163.00K
Exchange NYSE
Shares Outstanding 166.01M
Market Cap 6.10B
EPS 1.60
P/E Ratio 22.60
Div & Yield 0.29 (0.74%)
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a securities class action lawsuit against Dr.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Dr. Reddy's Laboratories Ltd.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Dr. Reddy's Laboratories Ltd.

The Klein Law Firm announces the commencement of an investigation of Dr.

SHAREHOLDER ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited

SHAREHOLDER ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Dr.

DR. REDDY LOSS NOTICE: Rosen Law Firm Reminds Dr. Reddy's Laboratories Ltd. Investors Of Important Deadline In First Filed Class Action

DR. REDDY LOSS NOTICE: Rosen Law Firm Reminds Dr. Reddy's Laboratories Ltd. Investors Of Important Deadline In First Filed Class Action

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Dr.

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited And Encourages Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Dr.

Dr. Reddy's Laboratories Breathes New Life Into Doan's® In New Marketing Campaign

Dr. Reddy's Laboratories Breathes New Life Into Doan's® In New Marketing Campaign

Dr. Reddy's Laboratories Ltd.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd.

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of Dr.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Dr. Reddy's Laboratories Ltd. - RDY

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Dr. Reddy's Laboratories Ltd. - RDY

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Dr.

Dr. Reddy's Q1 FY18 Financial Results

Dr. Reddy's Q1 FY18 Financial Results

Dr. Reddy's Laboratories Ltd.

Dr. Reddy's To Release Q1 FY18 Results On July 27, 2017

Dr. Reddy's To Release Q1 FY18 Results On July 27, 2017

Dr. Reddy's Laboratories (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) will announce results for the First Quarter ended June 30, 2017 on Thursday, July 27, 2017 after the Board Meeting.

Dr. Reddy's Laboratories Limited Announces Filing Of Annual Report On Form 20-F

Dr. Reddy's Laboratories Limited Announces Filing Of Annual Report On Form 20-F

Dr. Reddy's Laboratories Limited (NYSE: RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2017 was filed with the United...

Dr. Reddy's Laboratories Limited To Present At The Jefferies 2017 Global Healthcare Conference

Dr. Reddy's Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that the Company will be presenting at the Jefferies 2017 Global Healthcare Conference on Tuesday, June 6 th, 2017, in New York City.

Dr. Reddy's Q4 And FY17 Financial Results

Dr. Reddy's Laboratories Ltd.

Generics Drop Across Board as DOJ Inquiry Expands

Generics Drop Across Board as DOJ Inquiry Expands

The addition of Perrigo to the list of generics makers under investigation is more bad news for a sector already under pressure from low prices.

Dr. Reddy's Laboratories Announces The Launch Of Progesterone Capsules In The U.S. Market

Dr. Reddy's Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Progesterone Capsules, 100 mg and 200 mg, a therapeutic equivalent generic version of Prometrium ® (Progesterone)...

Dr. Reddy's And Integra LifeSciences Enter Into An Agreement To Market And Distribute DuraGen Plus® And Suturable DuraGen® Dural Regeneration In India

Dr. Reddy's Laboratories Limited (BSE:500124, NSE:DRREDDY, NYSE:RDY) and Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that they have entered into an...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AG, AMZN, CBPX, CTLT, FSM, GOLD, LADR, OHI Downgrades: ESRX, GCO, NXPI, OPB, PIP, RDY, TM Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Dr. Reddy's Q3 And 9M FY17 Financial Results

Dr. Reddy's Laboratories Ltd.

INVESTOR ALERT: Investigation Of Dr. Reddy's Laboratories Announced By Holzer & Holzer

INVESTOR ALERT: Investigation Of Dr. Reddy's Laboratories Announced By Holzer & Holzer

Holzer & Holzer, LLC is investigating whether certain statements issued during 2015 by Dr.

TheStreet Quant Rating: C (Hold)